M Joseph John, Chandrakala Shanmukhaiah, Toshirenla Aier, Neeraj Sidharthan, Renu Saxena, Shashikant Apte, Aby Abraham, Naresh Gupta, Soniya Nityanand, Cecil Ross, Tulika Seth, Alok Srivastava
{"title":"Cross-Sectional Survey of Haemophilia Treatment Centres (HTCs) in India: Towards a Context‑Sensitive Stratification Model","authors":"M Joseph John, Chandrakala Shanmukhaiah, Toshirenla Aier, Neeraj Sidharthan, Renu Saxena, Shashikant Apte, Aby Abraham, Naresh Gupta, Soniya Nityanand, Cecil Ross, Tulika Seth, Alok Srivastava","doi":"10.1111/hae.70095","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Haemophilia treatment centres (HTCs) coordinate multidisciplinary care, yet the European HTC standards on which global accreditation systems really do not reflect the wide resource gradient found in India.</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>To assess HTC capacities across India and explore a tiered stratification model suited to diverse settings.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A nationwide, self‑administered survey (February 2021–April 2022) was e‑mailed to all 291 HTCs registered with the Indian Association of Haemophilia and Allied Disorders. It captured infrastructure, laboratory capability and clinical services. Descriptive statistics and Spearman correlation were applied.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Ninety centres (30%) responded from 24 states/UTs. Only 34% fulfilled European HTC (EHTC) criteria and 11% met comprehensive‑care (EHCCC) criteria; 55% were unclassified despite providing haemophilia care. Laboratory‑to‑clinical functionality showed a moderate correlation (<i>r</i> = 0.61, <i>p</i> < 0.001). Twenty‑seven percent of centres operated without an onsite coagulation laboratory, whereas 40% lacked full‑time nurses and 60% lacked multidisciplinary teams. Factor VIII/IX supplies were uninterrupted at 31% of sites; 38% offered prophylaxis to at least one patient.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Rigid European categories mask the stepwise growth of Indian HTCs. A four‑tier model—anchored in predefined criteria for clinical and laboratory services could guide incremental upgrading while preserving patient safety.</p>\n </section>\n </div>","PeriodicalId":12819,"journal":{"name":"Haemophilia","volume":"31 5","pages":"973-980"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haemophilia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hae.70095","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Haemophilia treatment centres (HTCs) coordinate multidisciplinary care, yet the European HTC standards on which global accreditation systems really do not reflect the wide resource gradient found in India.
Aim
To assess HTC capacities across India and explore a tiered stratification model suited to diverse settings.
Methods
A nationwide, self‑administered survey (February 2021–April 2022) was e‑mailed to all 291 HTCs registered with the Indian Association of Haemophilia and Allied Disorders. It captured infrastructure, laboratory capability and clinical services. Descriptive statistics and Spearman correlation were applied.
Results
Ninety centres (30%) responded from 24 states/UTs. Only 34% fulfilled European HTC (EHTC) criteria and 11% met comprehensive‑care (EHCCC) criteria; 55% were unclassified despite providing haemophilia care. Laboratory‑to‑clinical functionality showed a moderate correlation (r = 0.61, p < 0.001). Twenty‑seven percent of centres operated without an onsite coagulation laboratory, whereas 40% lacked full‑time nurses and 60% lacked multidisciplinary teams. Factor VIII/IX supplies were uninterrupted at 31% of sites; 38% offered prophylaxis to at least one patient.
Conclusion
Rigid European categories mask the stepwise growth of Indian HTCs. A four‑tier model—anchored in predefined criteria for clinical and laboratory services could guide incremental upgrading while preserving patient safety.
期刊介绍:
Haemophilia is an international journal dedicated to the exchange of information regarding the comprehensive care of haemophilia. The Journal contains review articles, original scientific papers and case reports related to haemophilia care, with frequent supplements. Subjects covered include:
clotting factor deficiencies, both inherited and acquired: haemophilia A, B, von Willebrand''s disease, deficiencies of factor V, VII, X and XI
replacement therapy for clotting factor deficiencies
component therapy in the developing world
transfusion transmitted disease
haemophilia care and paediatrics, orthopaedics, gynaecology and obstetrics
nursing
laboratory diagnosis
carrier detection
psycho-social concerns
economic issues
audit
inherited platelet disorders.